Case reports on the innovative treatment option for persistent and drug refractory atrial fibrillation accompanying with tachycardia induced cardiomyopathy with LVEF of 25-30%.

22 May 2022 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Clinical cases - On demand Clinical ACNAP Premium Access ACNAP-EuroHeartCare 2022

ESC 365 is supported by

ESC 365 is supported by